期刊文献+

GALAD模型在原发性肝细胞癌诊断及微血管侵犯预测中的作用 被引量:10

Role of GALAD serological model in the clinical diagnosis of primary hepatocellular carcinoma
原文传递
导出
摘要 目的探讨G A L A D模型[包括性别(gender)、年龄(a g e)、甲胎蛋白(A F P)、甲胎蛋白异质体(A F P-L 3)、异常凝血酶原(D C P)]对原发性肝细胞癌诊断以及预测微血管侵犯(M V I)的价值。方法采用回顾性研究方法,选择20丨5年1月至2018年12月在东方肝胆外科医院接受根治性手术治疗的原发性肝细胞癌(H C C)患者5919例为研究组,选取同期良性肝脏疾病(B L D s)1745例为对照组,采用L U M I P U L S E G 1200全自动免疫分析仪检测D C P浓度,罗氏Cobas e 601全自动免疫分析仪检测血清A F P浓度,通过亲和吸附离心法检测A F P-L 3,两组间比较采用非参数M a n n-W h i t n e y检验,率的比较采用卡方检验,分析单个血清学标志物与G A L A D模型对原发性肝细胞癌的诊断价值,同时评价G A L A D模型对原发性肝细胞癌发生M V I的预测效能。结果与单个血清标志物相比,G A L A D模型对原发性肝细胞癌的诊断价值更高,在截断值为-0.33时,诊断敏感度、特异度和准确性分别为91.9%(5440/5919)、86.8%(1515/1745)和90.7%(6955/7664),曲线下面积可达0.960[95%C/(0.955~0.964)]。与未发现M V I(M n)相比,M V I低危组(M,)、M V I高危组(M 2)、发现M V I(M H2)的G A L A D模型值均显著升高(Z值分别为-12.517、-22.883、-21.655,/><0.05),〇六1^〇模型预测高危组M V I(M 2)曲线下面积为0.717[95%C M 0.701~0.733)](M。比M 2)。结论G A L A D模型用于原发性肝细胞癌的诊断性能更优,并对M V I具有一定的预测价值。 Objective To explore the value of GALAD model,including gender,age,AFP,AFP-L3 and DCP in diagnosis of primary hepatocellular carcinoma and prediction of microvascular invasion(MVI).Methods Using retrospective study method,5919 patients with primary hepatocellular carcinoma(HCC)who received radical operation from January 2015 to December 2018 in Eastern Hepatobiliary Surgery Hospital were enrolled into study group.At the same time,1745 patients with benign liver diseases(BLDs)were enrolled into control group.The concentration of DCP was detected by Lumipulse G1200 automatic immune analyzer,and the concentration of AFP was detected by Cobas e601 automatic immune analyzer.AFP-L3 was detected by affinity adsorption centrifugation.The non-parametric Mn n Whitney test was used to compare the difference between two groups.The chisquare test was used to compare the rates.The diagnostic value of single serological marker and GALAD model for primary hepatocellular carcinoma was analyzed.The predictive effect of GALAD model on MVI of primary hepatocellular carcinoma was evaluated.Results Compared with single serum marker,the diagnostic value of GALAD model is higher.When the cutoff value is-0.33,the diagnostic sensitivity,specificity and accuracy reach to 91.9%(5440/5919),86.8%(1515/1745)and 90.7%(6955/7664),respectively.T h e area under the curve can reach 0.960[95%CI(0.955-0.964)].Compared with no MVI(Mo)group,the value of GALAD model in MVI low-risk group(M,),MVI high-risk group(M2)and MVI(M1+2)were significantly higher(Z values were—12.517,-22.883,-21.655,P<0.05),Galad model predicts MVI(M2)in high risk group,AUC was 0.717[95%C I(0.701-0.733)](Moratio M J.Conclusion GALAD model has better diagnostic performance in primary hepatocellular carcinoma and has certain predictive value for microvascular invasion.
作者 童林 高致远 黄晨军 冯惠娟 孙小娟 季君 肖潇 房辑 高春芳 Tong Lin;Gao Zhiyuan;Huang Chenjun;Feng Huijuan;Sun Xiaojuan;Ji Jun;Xiao Xiao;Fang Meng;Gao Chunfang(Department o f Laboratory Medicine,Shanghai Eastern Hepatobiliary Surgery Hospital,Shanghai 200438,China)
出处 《中华检验医学杂志》 CAS CSCD 北大核心 2019年第12期1037-1041,共5页 Chinese Journal of Laboratory Medicine
基金 国家科技重大专项(2018ZX10302205-003) 上海市科委重点项目(17JC1404500) 海军军医大学成果培植项目(2017-CGPZ-B09)。
关键词 肝细胞 肝肿瘤 肿瘤浸润 微血管 甲胎蛋白类 凝血酶原 Carcinoma,hepatocellular Liver neoplasms Neoplasm invasiveness Microvessels alpha-Fetoproteins Prothrombin
  • 相关文献

参考文献3

二级参考文献72

  • 1Bing-Hui Yang, Jing-Lin Xia, Li-Wen Huang, Zhao-You Tang, Ming-Shan Chen, Jin-Qing Li, An-Min Liang, Qin-Guo Mo, Hui-Shan Lu, Chao-Liu Dai, Lu-Nan Yan, Zhi-Jian Yu, Rong-Sheng Rao, Le-Qun Li, Zhi-Xiong Su, Zhuang-Wei Fang Shanghai, China Liver Cancer Institute & Zhongshan Hospital, Fudan University, Shanghai 200032, China,Tumor Hospital, Zhongshan University, Guangzhou 510000, China Tumor Hospital, Guangxi Medical Universi- ty, Nanning 530000, China,Xiehe Hospital, Fujian Medical University, Fuzhou 350000, China,Second Hos- pital, Chinese Medical University, Shenyang 110000, China ,Huaxi Hospital, Sichuan University, Chengdu 610041, China ,Hospital Affiliated to Nantong Medical University, Nantong 226000 , China,Second Hospital, Jiangxi Medical University, Nanchang 330000 , China ,First Hospital Affiliated to Guangxi Medical University, Nanning 530000 , China ,People’s Hospital of Hainan Province, Haikou 570000, China.Changed clinical aspects of primary liver cancer in China during the past 30 years[J].Hepatobiliary & Pancreatic Diseases International,2004,3(2):194-198. 被引量:20
  • 2青柳豊,韩少良.甲胎蛋白(AFP)L3组分[J].日本医学介绍,2005,26(2):49-50. 被引量:37
  • 3赵云鹏,高春芳.糖组学研究在肝病中的应用进展[J].第二军医大学学报,2007,28(5):538-541. 被引量:7
  • 4吴孟超.应重视小肝癌的诊断与治疗[J].中华医学杂志,2007,87(30):2089-2091. 被引量:11
  • 5Jiang DK,Sun J,Cao G. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma[J].Nature genetics,2013.72-75.
  • 6Beasley RP,Hwang LY,Lin CC. Hepatocellular carcinoma and hepatitis B virus.A prospective study of 22 707 men in Taiwan[J].LANCET,1981.1129-1133.
  • 7Yin J,Xie J,Zhang H. Significant association of different preS mutations with hepatitis B-related cirrhosis or hepatocellular carcinoma[J].Journal of Gastroenterology,2010.1063-1071.
  • 8Liu S,Zhang H,Gu C. Associations between hepatitis B virus mutations and the risk of hepatocellular carcinoma:a meta-analysis[J].JOURNAL OF THE NATIONAL CANCER INSTITUTE,2009.1066-1082.
  • 9Mu(n)oz A,Chen JG,Egner PA. Predictive power of hepatitis B 1762T/1764A mutations in plasma for hepatocellular carcinoma risk in Qidong,China[J].CARCINOGENESIS,2011.860-865.
  • 10Yeh C,So M,Ng J. Hepatitis B virus-DNA level and basal core promoter A1762T/G1764A mutation in liver tissue independently predict postoperative survival in hepatocellular carcinoma[J].HEPATOLOGY,2010.1922-1933.

共引文献127

同被引文献97

引证文献10

二级引证文献51

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部